Literature DB >> 13611573

A controlled trial of meprobamate in anxious out-patients.

J M HINTON.   

Abstract

Entities:  

Keywords:  ANXIETY/therapy; MEPROBAMATE/therapeutic use

Mesh:

Substances:

Year:  1958        PMID: 13611573      PMCID: PMC497334          DOI: 10.1136/jnnp.21.4.301

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  7 in total

1.  Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate).

Authors:  L S SELLING
Journal:  J Am Med Assoc       Date:  1955-04-30

2.  Reserpine in the treatment of anxious and depressed patients.

Authors:  D L DAVIES; M SHEPHERD
Journal:  Lancet       Date:  1955-07-16       Impact factor: 79.321

3.  Meprobamate in the treatment of tension states.

Authors:  G C HELLER; D WALTON; D A BLACK
Journal:  J Ment Sci       Date:  1957-07

4.  Use of meprobamate in tension states.

Authors:  A FOLKSON
Journal:  J Ment Sci       Date:  1957-10

5.  Controlled trial of meprobamate.

Authors:  A FERNANDES DA FONSECA; E D WEST
Journal:  Br Med J       Date:  1956-11-24

6.  Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states.

Authors:  J C BORRUS
Journal:  J Am Med Assoc       Date:  1955-04-30

7.  The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent.

Authors:  F M BERGER
Journal:  J Pharmacol Exp Ther       Date:  1954-12       Impact factor: 4.030

  7 in total
  1 in total

1.  Today's drugs. Benzodiazepines.

Authors: 
Journal:  Br Med J       Date:  1967-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.